| Primary information |
|---|
| sequence ID | Seq_1075 |
| Peptide sequence | DAAYMNKV |
| CancerPDF_ID | CancerPDF_ID11336, CancerPDF_ID12649, |
| PMID | 26992070,26992070 |
| Protein Name | "Keratin, type II cytoskeletal 5","Keratin, type II cytoskeletal 5" |
| UniprotKB Entry Name | K2C5_HUMAN,HBB_HUMAN |
| Fluid | Serum,Serum |
| M/Z | NA,NA |
| Charge | NA,NA |
| Mass (in Da) | 911.4280871,927.4221057 |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | LC-MS/MS,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | FDR 1 %,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID11336, CancerPDF_ID12649, |
| p-Value | NA,NA |
| Software | SEQUEST and Maxquant,"Maxquant,Proteome Discoverer" |
| Length | 8,8 |
| Cancer Type | Melanoma,Melanoma |
| Database | SwissProt Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 8 cancer samples and 4 healthy samples,8 cancer samples and 4 healthy samples |
| Regulation | "Present in 2 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples.","Present in 2 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." |
| Validation | na,NA |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |